Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2026-02-19 @ 9:52 PM
Study NCT ID:
NCT00319735
Status:
COMPLETED
Last Update Posted:
2016-04-28
First Post:
2006-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas
Sponsor:
Nasser Hanna, M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HOG GI05-92
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None